What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
His primary areas of study are Internal medicine, Endocrinology, Renal function, Kidney disease and Albuminuria.
His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Nephropathy and Type 2 diabetes.
His biological study spans a wide range of topics, including Risk factor and Urology.
His Renal function study integrates concerns from other disciplines, such as Nephrology, Heart failure, Cardiology, Kidney and Enalapril.
His Kidney disease research includes themes of Gastroenterology, Dialysis, End stage renal disease and Intensive care medicine.
His Albuminuria study also includes fields such as
- Diabetic nephropathy that intertwine with fields like Ramipril,
- Surgery that intertwine with fields like Placebo-controlled study.
His most cited work include:
- EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY (5734 citations)
- Canagliflozin and cardiovascular and renal events in type 2 diabetes (2888 citations)
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) (2383 citations)
What are the main themes of his work throughout his whole career to date?
Dick de Zeeuw mainly investigates Internal medicine, Endocrinology, Renal function, Albuminuria and Kidney disease.
His research integrates issues of Cardiology, Diabetes mellitus, Nephropathy, Type 2 diabetes and Urology in his study of Internal medicine.
His Diabetes mellitus research focuses on Intensive care medicine and how it relates to Clinical trial.
His research in Urology focuses on subjects like Losartan, which are connected to Pharmacology.
Dick de Zeeuw has included themes like Nephrology, Urinary system, Creatinine, Prospective cohort study and End stage renal disease in his Renal function study.
His Albuminuria research integrates issues from Surgery, Urine, Microalbuminuria and Risk factor.
He most often published in these fields:
- Internal medicine (71.45%)
- Endocrinology (40.20%)
- Renal function (31.42%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (71.45%)
- Type 2 diabetes (24.49%)
- Kidney disease (26.52%)
In recent papers he was focusing on the following fields of study:
Dick de Zeeuw focuses on Internal medicine, Type 2 diabetes, Kidney disease, Canagliflozin and Albuminuria.
The study incorporates disciplines such as Diabetes mellitus, Endocrinology, Placebo and Cardiology in addition to Internal medicine.
His Type 2 diabetes research incorporates elements of Metformin, Oncology, Blood pressure, Post-hoc analysis and Hazard ratio.
His research investigates the link between Canagliflozin and topics such as Heart failure that cross with problems in Myocardial infarction.
His Albuminuria research is multidisciplinary, relying on both Surgery, Cohort study, Microalbuminuria, Excretion and Surrogate endpoint.
His research in Renal function intersects with topics in Biomarker, Urology, Disease, Creatinine and Prospective cohort study.
Between 2015 and 2021, his most popular works were:
- Canagliflozin and cardiovascular and renal events in type 2 diabetes (2888 citations)
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study) (228 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Kidney
The scientist’s investigation covers issues in Internal medicine, Kidney disease, Diabetes mellitus, Type 2 diabetes and Canagliflozin.
His Internal medicine research is multidisciplinary, incorporating perspectives in Empagliflozin, Placebo, Endocrinology and Cardiology.
Dick de Zeeuw focuses mostly in the field of Kidney disease, narrowing it down to topics relating to Renal function and, in certain cases, Urology, Clinical trial and Randomized controlled trial.
Dick de Zeeuw combines subjects such as Cohort and MEDLINE with his study of Diabetes mellitus.
His Type 2 diabetes research is multidisciplinary, incorporating elements of Creatinine, Gastroenterology and Blood pressure.
His work carried out in the field of Albuminuria brings together such families of science as Surgery, Microalbuminuria and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
